• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

监禁期间阿片类激动剂治疗的惩罚性中断。

Punitive discontinuation of opioid agonist therapy during incarceration.

机构信息

British Columbia Centre on Substance Use, Vancouver, Canada.

Department of Family and Community Medicine, University of Toronto, Toronto, Canada.

出版信息

Int J Prison Health. 2020 Aug 24;16(4):337-342. doi: 10.1108/IJPH-02-2020-0012.

DOI:10.1108/IJPH-02-2020-0012
PMID:33634666
Abstract

PURPOSE

The prevalence of substance use disorders among incarcerated individuals in Canada is substantially higher than in the general population. Many incarcerated individuals with opioid use disorder remain untreated due to inadequate access to opioid agonist therapy (OAT). A considerable proportion of overdose-related deaths in the province of Ontario are individuals who have recently been released from prison. The purpose of this paper is to highlight that discontinuation of OAT as a disciplinary measure remains an active concern within prisons in Canada and places individuals with opioid use disorder at increased risk of relapse and resultant overdose death.

DESIGN/METHODOLOGY/APPROACH: This case report describes an incarcerated client with opioid use disorder who was initially stable on OAT, but was forcibly tapered off OAT as a disciplinary measure and subsequently relapsed to illicit opioid use while in custody.

FINDINGS

This case calls attention to concerns regarding treatment of opioid use disorder during incarceration, as forcible detoxification from OAT as a disciplinary measure is a highly dangerous practice. The authors discuss concerns regarding diversion and ways in which prison-based OAT programs can be improved to increase their safety and acceptability among correctional staff. Ongoing advocacy is required on the part of health-care workers and policymakers to ensure that individuals are able to appropriately access this life-saving therapy while incarcerated.

ORIGINALITY/VALUE: To the best of the authors' knowledge, this is the first case report to describe forcible tapering of OAT as a disciplinary measure during incarceration. Despite existing evidence emphasizing the significant risk of overdose associated with detoxification from opioids, this case highlights the need for further research into the causes and prevalence of this practice.

摘要

目的

加拿大被监禁者中物质使用障碍的患病率明显高于一般人群。由于获得阿片类药物激动剂治疗(OAT)的机会不足,许多患有阿片类药物使用障碍的被监禁者仍未得到治疗。安大略省因过量用药而死亡的人数中,相当一部分是最近刚从监狱获释的人。本文旨在强调,将 OAT 停药作为一种纪律处分措施在加拿大监狱中仍然是一个活跃的关注点,这使患有阿片类药物使用障碍的人面临更高的复发和由此导致的过量死亡风险。

设计/方法/方法:本案例报告描述了一名患有阿片类药物使用障碍的被监禁者,他最初在 OAT 治疗下稳定,但因纪律处分而被迫逐渐减少 OAT,随后在监禁期间复发并重新使用非法阿片类药物。

发现

该案例引起了对监禁期间治疗阿片类药物使用障碍的关注,因为作为纪律处分的 OAT 强制脱毒是一种非常危险的做法。作者讨论了对药物滥用的担忧以及如何改进基于监狱的 OAT 计划,以提高其在狱警中的安全性和可接受性。卫生保健工作者和政策制定者需要持续倡导,以确保在监禁期间,个人能够适当获得这种救命治疗。

原创性/价值:据作者所知,这是第一个描述在监禁期间因纪律处分而强制减少 OAT 的案例报告。尽管现有证据强调了从阿片类药物戒断相关的严重过量风险,但该案例强调了需要进一步研究这种做法的原因和普遍性。

相似文献

1
Punitive discontinuation of opioid agonist therapy during incarceration.监禁期间阿片类激动剂治疗的惩罚性中断。
Int J Prison Health. 2020 Aug 24;16(4):337-342. doi: 10.1108/IJPH-02-2020-0012.
2
Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study.加拿大安大略省患有阿片类药物使用障碍(OUD)的联邦监狱服刑人员的阿片类激动剂治疗(OAT)经历与释放计划:一项混合方法研究
BMC Public Health. 2022 Mar 4;22(1):436. doi: 10.1186/s12889-022-12685-0.
3
Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.加拿大不列颠哥伦比亚省长期接受阿片类药物治疗疼痛的患者中,有无阿片类药物使用障碍者停用和逐渐减少处方阿片类药物与过量用药风险的关系:一项回顾性队列研究。
PLoS Med. 2022 Dec 1;19(12):e1004123. doi: 10.1371/journal.pmed.1004123. eCollection 2022 Dec.
4
Receipt of Opioid Agonist Treatment in provincial correctional facilities in British Columbia is associated with a reduced hazard of nonfatal overdose in the month following release.在不列颠哥伦比亚省的省级监狱设施中接受阿片类激动剂治疗与释放后一个月内非致命性过量的风险降低有关。
PLoS One. 2024 Jul 10;19(7):e0306075. doi: 10.1371/journal.pone.0306075. eCollection 2024.
5
Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.监禁人员中与阿片类药物相关的治疗、干预措施和结果:系统评价。
PLoS Med. 2019 Dec 31;16(12):e1003002. doi: 10.1371/journal.pmed.1003002. eCollection 2019 Dec.
6
Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada.在加拿大温哥华,监禁中的阿片类药物使用障碍者中使用阿片类激动剂治疗的情况。
Drug Alcohol Depend. 2018 Dec 1;193:42-47. doi: 10.1016/j.drugalcdep.2018.09.003. Epub 2018 Oct 6.
7
Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia.建模澳大利亚新南威尔士州 2001 年至 2020 年期间接受治疗的人群中阿片类激动剂治疗对死亡率的人群水平影响。
Addiction. 2022 May;117(5):1338-1352. doi: 10.1111/add.15736. Epub 2021 Dec 4.
8
Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study.有注射吸毒史人群对监狱内阿片类激动剂治疗可及性的认知:一项定性研究。
J Subst Use Addict Treat. 2023 Jul;150:209066. doi: 10.1016/j.josat.2023.209066. Epub 2023 May 6.
9
Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: A survey.加拿大安大略省省级惩教设施中医生开具阿片类激动剂治疗药物的情况:一项调查。
PLoS One. 2018 Feb 15;13(2):e0192431. doi: 10.1371/journal.pone.0192431. eCollection 2018.
10
Medications for opioid use disorder in state prisons: Perspectives of formerly incarcerated persons.州立监狱中阿片类药物使用障碍的药物治疗:曾被监禁者的观点。
Subst Abus. 2022;43(1):964-971. doi: 10.1080/08897077.2022.2060448.

引用本文的文献

1
National consensus statement on opioid agonist treatment in custodial settings.关于监禁场所阿片类激动剂治疗的全国共识声明。
Med J Aust. 2025 Mar 17;222(5):262-268. doi: 10.5694/mja2.52603. Epub 2025 Mar 2.
2
Normalizing fentanyl: interpreting the perceived 'risk' of correctional officer work.使芬太尼正常化:解读矫正官员工作的所谓“风险”。
Addict Sci Clin Pract. 2024 Sep 29;19(1):70. doi: 10.1186/s13722-024-00504-3.
3
The State of Mental Health Services for Incarcerated Adults in Ontario: A Scoping Review.安大略省成年在押人员心理健康服务状况:一项范围综述
Int J Offender Ther Comp Criminol. 2025 Apr;69(5):630-654. doi: 10.1177/0306624X241228218. Epub 2024 Feb 5.
4
Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper.美沙酮减量治疗后阿片类药物过量相关的处方特征。
JAMA Netw Open. 2022 Sep 1;5(9):e2234168. doi: 10.1001/jamanetworkopen.2022.34168.